Advertisement
Home 2015 October

Monthly Archives: October 2015

For new entries into health care with low back pain

Type of Provider Impacts Health Care Utilization in LBP

0
For new entries into care with low back pain, health care use up with physiatry versus primary care
Proteomic blood profiling has identified new circulating biomarkers for homeostasis model assessment of insulin resistance

New Protein Biomarker Identified in Insulin Resistance

0
Cathepsin D identified as new insulin resistance biomarker; IR seems to have causal effect on t-PA
In adults with episodic migraine

Simvastatin, Vitamin D3 Combo Helps Prevent Migraines

0
Treatment effective for preventing headache in adults with episodic migraine
Modification of the traditional Subjective-Objective-Assessment-Plan presentation to consider value can help medical students learn to practice high-value

Modified SOAP Ups Student Awareness of Health Care Costs

0
Modification of traditional SOAP presentation to include discussion of value helps medical students
Humanism

Modern Health Care Environment Challenges Humanistic Practice

0
Important to maintain focus on humanistic practices in modern health care environment
Adoption of a recommended bundle of prevention behaviors is associated with a reduction in the pediatric surgical site infection rate

Prevention Bundle Can Cut Rate of Pediatric SSIs

0
Twenty-one percent reduction in SSI rate reported across network hospitals
A nutrigenetic-based diet does not increase weight loss

Nutrigenetic-Based Diet Doesn’t Increase Weight Loss

0
But, genetic features identify patients likely to benefit from a balanced diet strategy
The incidence of cytomegalovirus infection/disease is reduced in de novo kidney transplant recipients receiving reduced dose tacrolimus and everolimus

Reduced-Dose Tacrolimus, Everolimus Cuts CMV Infection

0
Findings in de novo kidney recipients receiving no pharmacologic CMV prophylaxis
Menstrual preconditioning could prevent major obstetrical syndromes in women with polycystic ovary syndrome

Menstrual Preconditioning May Prevent PCOS-Tied Complications

0
Induction of ovulation should be preceded by period of progesterone withdrawal bleeding
Keytruda (pembrolizumab) has been approved by the U.S. Food and Drug Administration to treat advanced cases of non-small-cell lung cancer with tumors that express the PD-L1 protein. Keytruda is approved for use with the PD-L1 IHC 22C3 pharmDx test

FDA Approves Keytruda for Advanced NSCLC

0
Approved for use with PD-L1 IHC 22C3 pharmDx test